Dashboard
1
High Management Efficiency with a high ROE of 19.26%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 77.55
3
High Debt company with Weak Long Term Fundamental Strength
4
Flat results in Dec 24
5
With ROE of 9.50%, it has a Fair valuation with a 1.71 Price to Book Value
6
Market Beating Performance
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
69.62%
0%
69.62%
6 Months
75.55%
0%
75.55%
1 Year
84.88%
0%
84.88%
2 Years
12.52%
0%
12.52%
3 Years
19.04%
0%
19.04%
4 Years
-39.69%
0%
-39.69%
5 Years
48.79%
0%
48.79%
China Medical System Holdings Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.25%
EBIT Growth (5y)
-8.17%
EBIT to Interest (avg)
77.55
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.31
Sales to Capital Employed (avg)
0.52
Tax Ratio
23.80%
Dividend Payout Ratio
40.22%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
27.22%
ROE (avg)
19.26%
Valuation key factors
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
1.71
EV to EBIT
14.64
EV to EBITDA
12.61
EV to Capital Employed
2.03
EV to Sales
3.08
PEG Ratio
0.91
Dividend Yield
NA
ROCE (Latest)
13.85%
ROE (Latest)
9.50%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
8,854.70
10,640.70
-16.78%
Operating Profit (PBDIT) excl Other Income
3,193.10
4,395.40
-27.35%
Interest
51.10
57.10
-10.51%
Exceptional Items
-263.00
151.10
-274.06%
Consolidate Net Profit
2,634.80
3,809.80
-30.84%
Operating Profit Margin (Excl OI)
332.00%
388.20%
-5.62%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is -16.78% vs 5.90% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -30.84% vs 4.49% in Dec 2022
About China Medical System Holdings Ltd. 
China Medical System Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






